Prospective Randomized Trial of Postoperative Adjuvant Therapy in Patients with Completely Resected Stage II and Stage IIIa Non-Small Cell Lung Cancer, Intergroup
Research committees
Publication Information Expand/Collapse
2004
EGFr dinucleotide repeat polymorphism in non-small cell lung cancer
2003
Post-operative radiotherapy (PORT) or chemoradiotherapy (CPORT) following resection of stages II and IIIa non-small cell lung cancer (NSCLC) leads to higher than expected risk of death from intercurrent disease (DID).
2002
The influence of gender on survival and tumor recurrence following adjuvant therapy of cmopletely resected stages II and IIIa non-small cell lung cancer.
2000
A randomized trial of postoperative adjuvant therapy in patients with completely resected stage II or IIIA non-small-cell lung cancer
1999
Prospective randomized trial of postoperative adjuvant therapy in patients with completely resected stages II and IIIa non-small cell lung cancer: an Intergroup trial (E3590).
1994
Cisplatin (P) & etoposide (E) + concurrent thoracic radiotherapy (TRT) administered once versus twice daily for limited-stage (LS) small cell lung cancer (SCLC): Preliminary results of an intergroup trial.